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Abstract Nitric oxide biosynthesis in cardiac muscle leads to a
decreased oxygen consumption and lower ATP synthesis. It is
suggested that this effect of nitric oxide is mainly due to the
inhibition of the mitochondrial respiratory chain enzyme,
cytochrome c oxidase. However, this work demonstrates that
nitric oxide is able to inhibit soluble mitochondrial creatine
kinase (CK), mitochondrial CK bound in purified mitochondria,
CK in situ in skinned fibres as well as the functional activity of
mitochondrial CK in situ in skinned fibres. Since mitochondrial
isoenzyme is functionally coupled to oxidative phosphorylation,
its inhibition also leads to decreased sensitivity of mitochondrial
respiration to ADP and thus decreases ATP synthesis and
oxygen consumption under physiological ADP concentrations.
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1. Introduction
Recent studies have suggested that oxygen consumption in
cardiac muscle is negatively regulated by nitric oxide (NO).
Decreases in myocardial oxygen consumption rate have been
observed in isolated rat hearts perfused with NO solutions [1].
Furthermore, inhibition of NO formation has been shown to
increase the myocardial oxygen consumption [2]. Two major
mechanisms have been thought to be responsible for this ef-
fect: NO reduces the activity of several mitochondrial en-
zymes irreversibly via nitrosylation of the iron-sulphur centres
and reversibly by interacting with the haem group of cyto-
chrome c oxidase (for review, see [3]). However, the levels
of NO that have been used to nitrosylate the iron-sulphur
centres are very high relative to the levels of NO likely to
occur in vivo. At the same time, the inhibition of cytochrome
c oxidase occurs at relatively lower concentrations, suggesting
that its inhibition may be the main mechanism by which NO
decreases the oxygen consumption and thus decreases the
ATP synthesis [3,4]. Nevertheless, there are two recent reports
[5,6] showing that NO is able to inhibit MM-type creatine
kinase at very low concentrations. Creatine kinases (CK) are
key enzymes of energy metabolism, responsible for phosphor-
yl transfer between ATP and phosphocreatine in mitochon-
dria (mitochondrial isoform) and in extramitochondrial spaces
(MM, MB, and BB isoforms). Mitochondrial isoenzyme (mi-
CK) is functionally coupled to oxidative phosphorylation
through its close proximity to the ATP-ADP translocator
on the inner mitochondrial membrane (for review, see [7]).
Because of this close co-localisation, nascent ADP does not
readily di¡use out of the mitochondrial intermembrane space,
but rather is transported back into the mitochondrial matrix
via the adenine nucleotide translocase [8]. This increases the
ADP concentration that can be used for ATP synthesis that in
turn leads to an increased rate of oxygen consumption. Thus,
if NO inhibits also mi-CK, this inhibition may therefore lead
to a signi¢cant decrease in oxygen consumption and ATP
production by changes in kinetics of ADP regulation. To
test this hypothesis, an attempt was made to determine
whether the catalytic and functional activities of mi-CK are
inhibited in situ by a NO donor.
2. Materials and methods
2.1. Preparation of mitochondria and skinned ¢bres
Adult Wistar rats were anaesthetised with pentobarbital, the hearts
were removed and minced in ice-cold Krebs solution. Pieces of the
tissue were incubated for 15 min with 0.125 mg/ml trypsin and then
for a few minutes with trypsin inhibitor (0.3 mg/ml). The pieces were
collected and homogenised with a glass-te£on homogeniser in medium
containing 300 mM sucrose, 10 mM HEPES, 0.2 mM EDTA and
1 mg/ml BSA (pH 7.2). The resulting homogenate was centrifuged
(600Ug for 10 min at 4‡C), the supernatant was collected and centri-
fuged again (8000Ug for 15 min). The resulting pellet was washed
twice and kept at 4‡C until use. Part of the mitochondria was solu-
bilised by adding 1% Triton X-100.
For skinned ¢bre preparation, thin ¢bre bundles (6 250 Wm in
diameter) were excised from the subendocardial surface of the left
ventricle. The bundles were incubated with shaking for 30 min in a
solution containing 7.23 mM K2EGTA, 2.77 mM CaK2EGTA (free
[Ca2] 0.1 WM), 6.56 mM MgCl2 (free [Mg2] 1 mM), 5.7 mM Na-
2ATP, 15 mM phosphocreatine, 20 mM taurine, 0.5 mM DTT, 20
mM imidazole, 50 mM potassium methane sulphonate (pH 7.1) and
50 Wg/ml saponin to selectively destroy the sarcolemma. The ¢bres
were then washed and kept in the same solution without saponin.
All these procedures were carried out at 4‡C.
2.2. Catalytic activity of CK
CK activity was assayed using the coupled-enzyme system of glu-
cose 6-phosphate dehydrogenase (G-6-PDH) and hexokinase by meas-
uring NADPH production at 340 nm in the solution for respiration
(R, see below) containing, in addition, ADP 1 mM, AMP 10 mM,
glycose 20 mM, magnesium acetate 3 mM, NADP 5 mM, phospho-
creatine 10 mM, sodium azide 5 mM, hexokinase 2 U/ml, G-6-PDH 2
U/ml at a pH 7.1 and 22‡C. Reaction was initiated by ¢bre addition.
Puri¢ed MM-CK was obtained from Sigma Chemical Co.
2.3. Functional activity of mi-CK
The saponin-permeabilised bundles were transferred into solution R
containing 7.23 mM K2EGTA, 2.77 mM CaK2EGTA (free [Ca2] 0.1
WM), 1.38 mM MgCl2 (free [Mg2] 1 mM), 3 mM KH2PO4, 20 mM
taurine, 90 mM potassium methane sulphonate, 10 mM sodium meth-
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ane sulphonate, 20 mM imidazole (pH 7.1), 5 mM glutamic acid and
2 mM malic acid for 10 min to wash out adenine nucleotides and PCr.
Respiratory rates were determined by a Clark electrode in an oxy-
graphic cell in 3 ml of the same solution at 22‡C with continuous
stirring. After measurement, the bundles were removed and dried.
Respiration rates were expressed as nmol O2/min/mg dry weight.
The solubility of oxygen was taken to be 230 nmol O2/ml.
To determine the dependencies of respiration on external [ADP],
the ¢bres were exposed to increasing [ADP] in the presence (20 mM)
or in the absence of creatine. The ADP-stimulated respiration above
basal oxygen consumption was plotted in order to determine the ap-
parent Km for ADP.
2.4. Statistical analysis
The data are expressed as the mean þ S.E.M. Mean values were
compared using one-way ANOVA. A di¡erence was considered stat-
istically di¡erent when the P value was less than 0.05. Non-linear ¢ts
to Michaelis-Menten kinetics were computed by a non-linear least-
squares routine.
3. Results
S-Nitrosoglutathione (SNOG) was used as an exogenous
NO-releasing agent because of its well characterised e¡ect of
inhibiting MM-type CK [6]. First, the e¡ect of SNOG on mi-
CK activity in Triton-solubilised and non-solubilised mito-
chondrial preparations was compared. Fig. 1 demonstrates
that SNOG concentrations in the range of 1035^1033 M
dose-dependently inhibited both soluble and bound mi-CK
activity. In both cases, half-maximal inhibition was achieved
at 30^35 WM SNOG. Thus, SNOG inhibited the activity of
both solubilised and bound mi-CK almost totally and the
sensitivities of the preparations to SNOG were similar.
Our next step was to determine the characteristics of mi-CK
inhibition by SNOG in skinned cardiac ¢bres which maintain
the architecture and spatial relationships between the intra-
cellular compartments. As shown in Fig. 1, SNOG inhibited
the CK activity in saponin-skinned ¢bres, but at signi¢cantly
higher doses (IC50 = 90 WM) than in mitochondrial or solubi-
lised mitochondrial preparations. To check if this higher re-
sistance of CK to SNOG is due to lower sensitivity of the
MM isoform in the ¢bres, we studied the e¡ect of SNOG
on commercially available MM-CK. We found that this iso-
enzyme in solution had a sensitivity to SNOG inhibition sim-
ilar to that of solubilised mi-CK (IC50 = 20 WM) (results not
shown).
Since CK reaction catalysed by the mitochondrial isoform
increases the availability of ADP for oxidative phosphoryla-
tion, the sensitivity of mitochondrial respiration to ADP can
be used as an index of mi-CK functional activity. Therefore
we tested how SNOG alters the sensitivity of mitochondrial
respiration for ADP in the presence or absence of the CK
substrate, creatine. In control experiments without SNOG,
the saponin-permeabilised ¢bres in the absence of ADP dem-
onstrated a relatively weak respiration (6.6 þ 0.7 Wmol O2/min/
mg dry weight; n = 6) that was considerably stimulated by
2 mM ADP (28.5 þ 2.9 Wmol O2/min/mg dry weight). This
gave an acceptor control ratio value as high as 4.53 þ 0.37.
SNOG inhibited mitochondrial respiration even in the ab-
sence of creatine (IC50 = 280 WM) which was obviously due
to the well-known inhibition of cytochrome c oxidase. To
eliminate this e¡ect we preincubated the ¢bres with 500 WM
SNOG and then measured the respiration parameters in the
solution containing no SNOG or reducing agents. Since cyto-
chrome c oxidase inhibition by NO is completely reversible
but nitrosylation of CK is more or less irreversible, we ex-
pected that removal of SNOG reverses the e¡ect of SNOG on
cytochrome c oxidase but not on mi-CK. Indeed, our experi-
ments showed that such an incubation changed neither max-
imal ADP-stimulated respiration (29.1 þ 2.2 Wmol O2/min/mg
dry weight; n = 5) nor the acceptor control ratio. Nevertheless,
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Fig. 1. Inhibition of creatine kinase in di¡erent preparations by
SNOG. Preparations were incubated for 10 min in the presence of
various concentrations of SNOG. Each point represents a single
separate experiment. Values are represented as a percentage of the
value of the control incubated without SNOG.
Fig. 2. Actual recording of changes in creatine kinase reaction over
time. There was a signi¢cant decrease in the slope after the addition
of SNOG. The removal of SNOG led to only partial recovery of
CK activity.
Fig. 3. E¡ect of ADP on O2 consumption by skinned ¢bres preincu-
bated without and with 500 WM SNOG. Values are presented as
mean þ S.E.M., n = 3^5.
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65% of previously inhibited CK-speci¢c activity still remained
inhibited after removing SNOG from the reaction media
(Fig. 2). However, CK activity recovered when 1 mM DTT
was added to the reaction media.
The respiration experiments performed using the same pro-
tocol demonstrate that addition of creatine into the respira-
tion media decreased the Km for ADP in control ¢bres from
246 þ 6 WM to 70 þ 7 WM (n = 3) (Fig. 3). These creatine-de-
pendent decrease in Km re£ects the functional activity of mi-
CK. At the same time, in the SNOG-preincubated group,
creatine decreased Km from 238 þ 9 WM only to 177 þ 22 WM
(n = 3^5; P = 0.01 compared with control). Thus, preincuba-
tion with SNOG signi¢cantly depresses the functional activity
of mi-CK.
4. Discussion
NO has been implicated in many di¡erent physiological
responses and pathological conditions. It has been reported
that in ischaemic central nervous system the concentration of
NO can rise to higher than 10 WM [9]. These concentrations
are probably high enough to inhibit mitochondrial enzymes
involved in aerobic energy production. Here we demonstrate
that a nitric oxide donor also inhibits mi-CK speci¢c activity
both in vitro and in situ in skinned ¢bres as well as the func-
tional activity of mi-CK. Creatine kinase possesses eight sul-
phydryl groups and it has been suggested that the inhibition
by NO involves S-nitrosylation of critical sulphydryl groups
of this enzyme [10]. Konorev et al. [11] and Stachowiak et al.
[12] have recently shown that also peroxynitrite irreversibly
inhibited CK, including mi-CK. However, in our ¢bres most
of the inhibited CK activity recovered after removal of SNOG
in the presence but not in the absence of 1 mM DTT. This
strongly suggests that NO but not peroxynitrite was respon-
sible for the inhibition of CK in our preparations.
The results obtained show that CK bound to the intracel-
lular structures in ¢bres is less sensitive to NO than the solu-
bilised enzyme or mi-CK in isolated mitochondria. Since the
saponin-permeabilised ¢bres also contain MM-CK bound to
myo¢brils, sarcoplasmic reticulum, resting parts of the sarco-
lemma, one may suggest that all these enzymes are more re-
sistant to NO than mi-CK. Such a higher stability of mi-CK
in ¢bres could be a result of a relatively slow di¡usion of the
NO donor to the enzymes. It is not surprising taking into
consideration the much lower sensitivity to ADP found in
permeabilised isolated cardiomyocytes than in isolated mito-
chondria [13]. Though NO is believed to be freely di¡usible
[14], a rapid decomposition of this substance may blunt its
e¡ects if the source of NO is not located in the same subcel-
lular compartment. This emphasises the important role of the
intracellular localisation of NO synthases, particularly those
situated in the mitochondrial compartment [15,16]. The lower
sensitivity of ¢bre CK to NO may also be due to the presence
of some protective factor in situ that could be lost during the
procedure of mitochondrial isolation.
We have shown that mi-CK inhibition by the NO donor
induces a considerable decrease in mitochondrial ADP sensi-
tivity. In contrast to the NO e¡ect of maximal mitochondrial
respiration capacity, this inhibition is not readily reversible.
This suggests a chemical modi¢cation of the enzyme probably
due to nitrosylation of essential group(s). Inhibition of mi-CK
signi¢cantly changes the regulation of the mitochondrial res-
piration. This inhibition, in turn, leads to decreased sensitivity
of mitochondrial respiration to ADP. In living cells where the
ADP is present at submaximal concentrations this decreased
sensitivity to ADP leads to a substantial decrease in energy
production and respiration rate. Interestingly, the inhibition
of mi-CK activity in our experimental conditions occurred at
lower concentrations of the NO donor than the e¡ect on
mitochondrial respiration via cytochrome c oxidase inhibition.
This allows us to suggest that the mi-CK inhibition combined
with the e¡ect of NO on the respiratory chain may play a very
important role in the mechanisms of inhibition of the mito-
chondrial energy production by NO.
However, the relevance of mi-CK inhibition by NO in vivo
remains still open. The cells containing glutathione (reducer of
nitrosylated SH residues) and less oxygen than was present in
our experiments may respond di¡erently to NO. However,
after ischemic injury resulting to depletion of the cellular
pools of glutathione and/or activation the synthesis of NO,
the inhibition of CK may be as relevant as the inhibition of
cytochrome c oxidase in regulation of energy production.
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